Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STEM: Tibolone effects on breast cancer tissue
NCT00725374Phase 3Completed
- Sponsor
- Organon & Co.
- Start
- Dec 2002
- Primary completion
- Apr 2005
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
01
Overview
A Phase 3 trial of tibolone in breast cancer, sponsored by Organon & Co.. Started Dec 2002; status: completed.
02
Drugs
tibolone
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00725374.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00725374.